Invited commentary.
Jessen
Michael E
ME
Department of Cardiovascular & Thoracic Surgery, University of Texas Southwestern Medical Ctr, 5323 Harry Hines Blvd Dallas, TX 75390-8879, USA. michael.jessen@utsouthwestern.edu
D000818:Animals; D002315:Cardiopulmonary Bypass / Q000009:adverse effects*; D005998:Glycine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D019272:Leukocyte Elastase / Q000037:antagonists & inhibitors* / Q000502:physiology; D008070:Lipopolysaccharides / Q000633:toxicity*; D011817:Rabbits; D012128:Respiratory Distress Syndrome / Q000517:prevention & control*; D013449:Sulfonamides / Q000627:therapeutic use*
D008070:Lipopolysaccharides; D013449:Sulfonamides; C069195:sivelestat; D019272:Leukocyte Elastase; D005998:Glycine